---
$id: https://graph.org.ai/products/commodity/51151529
$type: Product
source: UNSPSC
code: "51151529"
title: "Rivastigmine"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rivastigmine

**UNSPSC Code**: 51151529
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PKI06M3IW0. European Medicines Agency schedules Rivastigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10345MIG. Rivastigmine generally arises in the molecular formula C14H22N2O2. The term RIVASTIGMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 1 1998, list 39.) RIVASTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rivastigmine under HS 29242995 and SITC 51479. As of Q4 2014, RIVASTIGMINE remains the US FDA Preferred Term for this commodity. Rivastigmine bears US NLM identifiers UMLS ID C0649350 and NCI Concept Code C66519. SMILES: O(C1CC(C(N(C)C)C)CCC1)C(=O)N(CC)C.

